Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 3Terminated 1

Sponsor Class

INDUSTRY 3

Study Type

Observational 2Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1Myeloid 1

Conditions

Papillomavirus Infections 1Neoplasm Metastasis 1Lymphohistiocytosis, Hemophagocytic 1

Interventions

Cyclophosphamide 637Bevacizumab 552Paclitaxel 533Carboplatin 531Cisplatin 478pembrolizumab 452Gemcitabine 422Docetaxel 415Rituximab 386Radiotherapy 371Dexamethasone 349Doxorubicin 325Nivolumab 307Fluorouracil 286Capecitabine 260Prednisone 243Oxaliplatin 242Erlotinib Hydrochloride 242Etoposide 239Lenalidomide 231Cytarabine 230Trastuzumab 227Pemetrexed 219fludarabine phosphate 207Vincristine 207Leucovorin 207Cetuximab 207Filgrastim 204Bortezomib 191Methotrexate 181

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × Has results × Data Collection × Clear all
NCT02312960 2025-03-25

Radium-223 Dichloride Long-term Follow-up Program

Bayer

Phase 4 Completed
255 enrolled 31 charts
Tumor-Agnostic

Neoplasm Metastasis

NCT03259230 2024-09-19

Evaluation of IFNγ and Inflammatory Mediators in Patients With Malignancy-Associated Hemophagocytic Lymphohistiocytosis

Swedish Orphan Biovitrum

Completed
40 enrolled 43 charts
Myeloid

Lymphohistiocytosis, Hemophagocytic

NCT01101542 2018-07-23

Evaluation of Safety of a Vaccine Against Cervical Cancer in Healthy Korean Females

GlaxoSmithKline

Completed
3,091 enrolled 19 charts

Papillomavirus Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡